Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Intraductal, Noninfiltrating × In Situ Hybridization, Fluorescence × Clear all

Sponsor

Conditions

Waldenstrom Macroglobulinemia 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Dendritic Cell Sarcoma, Interdigitating 2 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Tamoxifen 6 Letrozole 4 Radiation 3 Anastrozole 3 afimoxifene 2 Trastuzumab 2 Surgical Procedures, Operative 2 Simvastatin 2 Sentinel Lymph Node Biopsy 2 Radiotherapy 2 Radiation Dose Hypofractionation 2 Neoadjuvant Therapy 2 Mastectomy, Segmental 2 Lapatinib 2 Gene Expression Profiling 2 trastuzumab biosimilar HLX02 1 telapristone acetate 1 sargramostim 1 polyphenon E 1 palbociclib 1 oxybutynin 1 liposomal doxorubicin 1 exemestane 1 Zoledronic Acid 1 UAB 30 1 Tea 1 Sugars 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡